Varex Imaging Corp (VREX) CEO details RSU vesting and tax withholding

Rhea-AI Filing Summary

Varex Imaging Corp President and CEO, who is also a director, reported equity award activity in company stock dated 12/10/2025. Previously granted restricted stock units (RSUs) converted into 26,652 and 47,613 shares of common stock as they vested, and 32,566 shares were withheld at a price of $11.7 to satisfy tax withholding obligations related to this vesting. After these transactions, the reporting person directly holds 231,892 shares of common stock.

On the same date, the officer received a new grant of 156,250 RSUs, which are scheduled to vest 50% on December 10, 2027 and 50% on December 10, 2029. Earlier RSU grants from December 10, 2021 and December 10, 2023 have already partially vested, with remaining portions scheduled to vest on December 10, 2027. Each RSU converts into one share of common stock upon vesting and delivery.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

SANYAL SUNNY

(Last) (First) (Middle)

C/O VAREX IMAGING CORP.

1678 S. PIONEER ROAD

(Street)

SALT LAKE CITY UT 84104

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Varex Imaging Corp [ VREX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President and CEO

3. Date of Earliest Transaction (Month/Day/Year)
12/10/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	12/10/2025		M		26,652	A	(1)	216,845	D
Common Stock	12/10/2025		M		47,613	A	(1)	264,458	D
Common Stock	12/10/2025		F		32,566(2)	D	$11.7	231,892	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	12/10/2025		M			26,652	(3)	(3)	Common Stock	26,652	$0	0	D
Restricted Stock Units	(1)	12/10/2025		M			47,613	(4)	(4)	Common Stock	47,613	$0	47,613	D
Restricted Stock Units	(1)	12/10/2025		A		156,250		(5)	(5)	Common Stock	156,250	$0	156,250	D

Explanation of Responses:

1. Each Restricted Stock Unit converts into common stock on a one-for-one basis.

2. These shares represent shares withheld for satisfaction of a tax withholding obligation arising as a result of the vesting of the Restricted Stock Units reported herein.

3. These Restricted Stock Units granted on December 10, 2021 vested 50% on December 10, 2023 and 50% on December 10, 2025. Vested shares will be delivered to the reporting person upon vest date.

4. These Restricted Stock Units granted on December 10, 2023 vested 50% on December 10, 2025, with the remaining 50% scheduled to vest on December 10, 2027. Vested shares will be delivered to the reporting person upon vest date.

5. These Restricted Stock Units granted on December 10, 2025 are scheduled to vest 50% on December 10, 2027 and 50% on December 10, 2029. Vested shares will be delivered to the reporting person upon vest date.

Remarks:

	/s/ Sunny S. Sanyal	12/12/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

Who is the reporting person in the Varex Imaging Corp (VREX) Form 4?

The reporting person is Sunny S. Sanyal, who serves as President and CEO of Varex Imaging Corp and is also a director of the company.

What stock transactions did Varex Imaging Corp (VREX) report on 12/10/2025?

On 12/10/2025, previously granted RSUs vested and converted into 26,652 and 47,613 shares of common stock, and 32,566 shares were withheld at $11.7 per share to cover tax withholding obligations.

How many Varex Imaging (VREX) shares does the CEO own after the reported transactions?

Following the reported transactions on 12/10/2025, the reporting person directly owns 231,892 shares of Varex Imaging Corp common stock.

What new restricted stock unit award did the Varex Imaging (VREX) CEO receive?

On December 10, 2025, the CEO received a new grant of 156,250 restricted stock units, each representing the right to receive one share of common stock upon vesting.

What is the vesting schedule for the new 156,250 RSUs at Varex Imaging (VREX)?

The 156,250 RSUs granted on December 10, 2025 are scheduled to vest 50% on December 10, 2027 and 50% on December 10, 2029, with vested shares delivered upon each vest date.

How do earlier Varex Imaging (VREX) RSU grants vest for the CEO?

RSUs granted on December 10, 2021 vested 50% on December 10, 2023 and 50% on December 10, 2025. RSUs granted on December 10, 2023 vested 50% on December 10, 2025, with the remaining 50% scheduled to vest on December 10, 2027.

What does each restricted stock unit (RSU) represent in the Varex Imaging (VREX) filing?

Each restricted stock unit converts into one share of Varex Imaging Corp common stock upon vesting, with shares delivered to the reporting person on the applicable vest date.